The existing literature examining PsP in an exclusively IDH mutant cohort is limited, though 1 retrospective study exists that examined 200 high-grade IDH mutant patients.6 This study looks at a smaller cohort of patients compared with our current study, primarily because of the lack of low-grade gliomas. The gene discussed is IDH1; the disease is central nervous system cancer.